BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2007) 80, 989-995
© 2007 British Institute of Radiology
doi: 10.1259/bjr/32814323

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, R M
Right arrow Articles by Moore, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, R M
Right arrow Articles by Moore, M

Full paper

Doses to critical organs following radiotherapy and concomitant imaging of the larynx and breast

R M Harrison, PhD M Wilkinson, DCR(T) D J Rawlings, MPhil and M Moore, IIPEM

Regional Medical Physics Department, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, UK

Correspondence: R M Harrison, PhD, Regional Medical Physics Department, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, UK. E-mail: r.m.harrison{at}ncl.ac.uk

The development of conformal radiotherapy carries with it the implication of an increased number of imaging procedures at various stages throughout the overall treatment, principally for verification at some, or all, of the treatment fractions. This raises the issue of the balance between the benefit of these additional imaging exposures and the associated risk of radiocarcinogenesis arising from them. As such, it is necessary to appreciate the doses to critical organs for which individual carcinogenic risks have been estimated. In this study, doses to these organs have been measured with lithium fluoride thermoluminescence dosimetry loaded in anthropomorphic phantoms and subjected to realistic radiotherapy treatments of the larynx and breast, including concomitant CT and electronic portal imaging exposures associated with localization and verification of these treatments. Even for large numbers of concomitant images of either modality, arising from imaging at every fraction, the leakage and scatter from the radiotherapy itself is shown to dominate the overall organ dose, with imaging procedures generally contributing 5–20% of the total organ dose.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
L J SAWYER, S A WHITTLE, E S MATTHEWS, H C STARRITT, and T P JUPP
Estimation of organ and effective doses resulting from cone beam CT imaging for radiotherapy treatment planning
Br. J. Radiol., July 1, 2009; 82(979): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
R M HARRISON
Doses to organs and tissues from concomitant imaging in radiotherapy: a suggested framework for clinical justification
Br. J. Radiol., December 1, 2008; 81(972): 970 - 974.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
BJR review of the year -- 2007
Br. J. Radiol., April 1, 2008; 81(964): 265 - 269.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2007 by the British Institute of Radiology.